Page last updated: 2024-11-04

sulfamethoxypyridazine and Heart Failure

sulfamethoxypyridazine has been researched along with Heart Failure in 1 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parsons, V1
Porter, A1
Dische, F1

Other Studies

1 other study available for sulfamethoxypyridazine and Heart Failure

ArticleYear
Cardiomyopathy and renal failure occurring in the puerperium.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1971, Volume: 78, Issue:6

    Topics: Acute Kidney Injury; Adult; Bacillus; Bacteriuria; Connective Tissue; Drug Hypersensitivity; Female;

1971